BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12631353)

  • 1. Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood.
    Srivastava T; Garola RE; Whiting JM; Alon US
    Kidney Int; 2003 Apr; 63(4):1374-81. PubMed ID: 12631353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children.
    Srivastava T; Garola RE; Singh HK
    Kidney Int; 2006 Aug; 70(3):529-35. PubMed ID: 16775597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
    Shankland SJ; Eitner F; Hudkins KL; Goodpaster T; D'Agati V; Alpers CE
    Kidney Int; 2000 Aug; 58(2):674-83. PubMed ID: 10916090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptopodin expression in idiopathic nephrotic syndrome of childhood.
    Srivastava T; Garola RE; Whiting JM; Alon US
    Kidney Int; 2001 Jan; 59(1):118-25. PubMed ID: 11135064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-cycle mechanisms involved in podocyte proliferation in cellular lesion of focal segmental glomerulosclerosis.
    Wang S; Kim JH; Moon KC; Hong HK; Lee HS
    Am J Kidney Dis; 2004 Jan; 43(1):19-27. PubMed ID: 14712423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical stress reduces podocyte proliferation in vitro.
    Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
    Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphological characteristics and expression of cell cycle regulatory proteins in cellular variants of idiopathic focal segmental glomerulosclerosis.
    Wang SX; Liu G; Zou WZ; Wang HY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):145-9. PubMed ID: 15100731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte expression of the CDK-inhibitor p57 during development and disease.
    Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ
    Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of cyclin-dependent kinase inhibitors in hyperplasia and hypertrophy of vascular smooth muscle cells].
    Xu D; Wang M; Liu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):680-3. PubMed ID: 11798949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
    Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
    Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.
    Barisoni L; Mokrzycki M; Sablay L; Nagata M; Yamase H; Mundel P
    Kidney Int; 2000 Jul; 58(1):137-43. PubMed ID: 10886558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and activity of cell cycle-regulatory proteins in normal and transformed corneal endothelial cells.
    Schönthal AH; Hwang JJ; Stevenson D; Trousdale MD
    Exp Eye Res; 1999 May; 68(5):531-9. PubMed ID: 10328966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas.
    Korgun ET; Celik-Ozenci C; Acar N; Cayli S; Desoye G; Demir R
    Histochem Cell Biol; 2006 Jun; 125(6):615-24. PubMed ID: 16491347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
    Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
    Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
    Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
    Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical stretch induces podocyte hypertrophy in vitro.
    Petermann AT; Pippin J; Durvasula R; Pichler R; Hiromura K; Monkawa T; Couser WG; Shankland SJ
    Kidney Int; 2005 Jan; 67(1):157-66. PubMed ID: 15610239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.